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Abstract
Background: It is widely accepted that research can lead to improved health outcomes. However, translating
research into meaningful impacts in peoples’ lives requires actions that stretch well beyond those traditionally
associated with knowledge creation. The research reported in this manuscript provides an international review
of health research funders’ efforts to encourage this process of research uptake, application and scaling, often
referred to as knowledge translation.
Methods: We conducted web-site review, document review and key informant interviews to investigate
knowledge translation at 26 research funding agencies. The sample comprises the regions of Australia, Europe
and North America, and a diverse range of funder types, including biomedical, clinical, multi-health domain,
philanthropic, public and private organisations. The data builds on a 2008 study by the authors with the same
international sample, which permitted longitudinal trend analysis.
Results: Knowledge translation is an objective of growing significance for funders across each region studied.
However, there is no clear international consensus or standard on how funders might support knowledge
translation. We found that approaches and mechanisms vary across region and funder type. Strategically tailored
funding opportunities (grants) are the most prevalent modality of support. The most common funder-driven
strategy for knowledge translation within these grants is the linking of researchers to research users. Funders
could not to provide empirical evidence to support the majority of the knowledge translation activities they
encourage or undertake.
Conclusions: Knowledge translation at a research funder relies on context. Accordingly, we suggest that the
diversity of approaches uncovered in our research is fitting. We argue that evaluation of funding agency efforts to
promote and/or support knowledge translation should be prioritised and actioned. It is paradoxical that funders’
efforts to get evidence into practice are not themselves evidence based.
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Background
It is widely accepted that research can lead to improved
health outcomes. However, uncovering health knowledge
through research can be challenging, costly and time-
consuming, and may fail to produce meaningful ad-
vances. Still, the expected positive benefits associated
with knowledge creation have led governments, founda-
tions and private institutions across the globe to dedicate
envelopes of their tax-base or endowment to this en-
deavour. Around the world, recent estimates suggest
that over US$ 100 billion is spent on biomedical re-
search alone in a single year [1].
That being said, the benefits of knowledge are rarely
achieved by its creation alone. Knowing what to do with
health-related knowledge – how to access it, appraise it,
tailor it for context, apply it in the practical world and
know when it is not appropriate for practical application –
is an entirely different challenge. Evidence indicates that
health knowledge continues to be converted into practical
applications in a slow and inconsistent way [2, 3]. The
rush of publicly funded organisations to address this issue
has been well documented in primary research and sys-
tematic reviews [4, 5]. Further, research funding agencies
have also answered the call. Effectively, research funders
have financed another charge for unlocking the power of
knowledge, by increasing their focus on the conversion of
knowledge into action. In this paper, we refer to this as
knowledge translation (KT). Simply put, KT is the process
of turning the knowledge that is generated in research
studies into use in the real-world. For example, an im-
proved product or device, a new policy or practice guide-
line, or a more accessible and thus equitable programme.
The most broadly accepted definition of this process is of-
fered by the Canadian Institutes of Health Research
(CIHR), which uses the term KT to articulate to their
Canadian constituency a support of:
“A dynamic and iterative process that includes
synthesis, dissemination, exchange, and ethically-
sound application of knowledge to improve the
health of Canadians, provide more effective health
services and products, and strengthen the health
care system.” [2]
The primary objective of the research reported in this
manuscript is to provide an international overview of
the state of health research funders’ efforts to promote
and support KT. To address this objective, the research
takes a broad view, looking across an international sam-
ple of 26 funding agencies to identify trends and
themes, rather than taking a deep dive into the particu-
lar practices of any single agency. In addition, the data
collected and analysed in this manuscript builds on our
previous work [6], which allows for longitudinal trend
analysis. In our 2008 project, 33 health research fund-
ing agencies from around the world were reviewed to
learn more about their KT roles and activities [6]. In
this follow-up, we have replicated the study design from
2008, and have been able to include 26 of these
agencies. A full account of our methods, findings and
conclusions are provided in the following sections of
this paper.
We believe the results of this study hold immediate
practical value. The primary intended users of this study
are health research funders. We hope this international
stock-taking will facilitate evidence-informed reflection
and debate amongst funders. Secondary users of this work
will include health and science policy-makers, as well as
researchers interested in KT (both those interested in the
study of KT, but also those wanting to learn more about
how they are being supported by funders to do KT).
Why focus on funders?
Health research funders are just one of many actors
in the pursuit of translating knowledge into action.
Many actors, including but not limited to re-
searchers, governments, patients, activists and tax-
payers, have grown increasingly concerned with
research being solution-oriented, and each plays an
important role in ensuring an effective balance is
struck between the creation of new knowledge and
its application to health needs.
Research funders are rarely in the business of research
implementation. However, we argue that the role of the
research funder in KT is particularly pertinent. Funders
control access to resources and therefore hold a position
of power. This power can be used to stimulate and in-
centivise action on the part of the research community,
including researchers, brokers and research users.
Evidence shows that funders contributing to KT have
potential for impact. In spite of identified roadblocks in
the knowledge-to-action pathway, studies examining the
return on investment of public research have shown
ample evidence of value [7, 8]. In simpler terms, re-
search is a good investment in the public good. For
example, one study performed by the Council of
Economic Advisors to the President of the United States
[9] demonstrated that the average social return on gov-
ernment investment in research and development was
above 50%, a figure that was at the time, and still is, far
greater than other areas of investment, including private
sector research and development [9]. As impact assess-
ment models that better capture the hard to measure
‘social impacts’ of research continue to evolve, we expect
to see investments in research appearing even more at-
tractive. Understanding how KT is supported by funders
will help to ensure these investments generate the great-
est return for people and society.
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At the same time, the two primary stakeholders of
the health research funder (the public and the
academic community) have voiced clear interest in
improved application and coordination of KT inter-
ventions by funders. The first stakeholder group, the
public (often the research funder’s funder, and always
the intended long-term beneficiary), has asserted a
concern that governments pay greater attention to en-
suring the practical utility of research they fund [10].
The second group, the academic community (the re-
search funder’s primary beneficiary) has increasingly
turned to funders to support their desire and build
their capacity to meet this growing public call for
knowledge translation [11, 12].
Methods
Study design
This research was undertaken with the intent of provid-
ing a comprehensive account of the international state
of KT support offered by health research funding agen-
cies in high-income countries. We adopted a longitu-
dinal study design, wherein data from the same cohort
was gathered across subsequent intervals in time. To do
this, we purposefully grounded our study design in the
work of Tetroe et al. [6] and McLean et al. [13].
Theoretical frameworks
Two theoretical frameworks were employed to support
data analysis. One to categorise KT activities and a sec-
ond to classify evaluation activities at funding agencies.
The first, in which we categorise, describe and provide
our assessments of funding agency support for KT, is de-
rived from the work of Lavis et al. [14]. In their 2006
paper, Lavis and colleagues propose a framework for
assessing country-level efforts to link research to action
with a view to “inform country-level dialogues about the
options for linking research to action” [14]. This frame-
work was applied in our data analysis as it provided an
internationally recognisable system for KT activity classi-
fication and interpretation. The framework outlines
three components into which we classify funding agency
KT activities, these are (1) push activities, (2) pull activ-
ities, and (3) linkage and exchange activities (Box 1). For
the reasons above, we believe this is a useful and rigor-
ous means of analysing the KT activities of funding
agencies. We caution that this framework does not facili-
tate a specific review of ‘priority-setting activities’ or ‘re-
sponsive grant-making’, i.e. when funding agencies
strategically prioritise topics, disciplines or objectives for
the research they fund. The KT activity classification
framework employed here includes funding that has
been ‘strategically prioritised’, but it does not examine
the act of priority-setting separately.
To conduct an analysis of evaluation activities, we
developed a new framework for funding agency
evaluation activity classification. The framework is
derived from theory and guidance on best practice
in evaluation [15–19], as well as the work of
Mintzberg on organisational strategy [20], and that
of the Canada’s International Development Research
Centre on how strategy and evaluation interact [21,
22]. Mintzberg argues that organisational strategy is
not just what we say we do, it is also what we do
[20, 22]. Because evaluation is used by organisations
to understand what has been done, in essence, evalu-
ation activities can be used to shine light on a pic-
ture of organisational strategy. In this research, we
aimed to utilise this dynamic conceptualisation of
organisational learning and strategic management by
developing a framework for the analysis of funders’
KT actions.
Box 1 Knowledge translation activity classification
framework
Push – activities and programmes targeted at the ‘pushing’ of
research-produced knowledge into the hands of appropriate
knowledge users – users who may not have otherwise been
aware of the research and its implications. Examples include
research communications, funding opportunities or funder
activities, or typical end-of-grant funds that an agency may
provide to a researcher to encourage the dissemination of
findings such a publication in an Open Access journal, or the
creation of a plain language findings brief.
Pull – activities and programmes that facilitate knowledge users’
access to research results. For example, a forum where researchers
are brought to discuss an issue of importance with identified
knowledge users.
Linkage and exchange – activities and programmes that
support the establishment of partnerships between researchers
and knowledge users through multiple parts of the process of
research design, execution and/or dissemination. Linkage and
exchange is also referred to as integrated knowledge translation
and co-creation/co-production [35–37]. An example would be a
research grant that required both a researcher and a knowledge
user to apply in partnership for funding, representing a break
with the traditional researcher curiosity-driven approach to
science. This more participatory approach may also involve
non-researchers (e.g. patients, clinicians, managers, etc.) as
reviewers in the peer-review process.
Note: This is a very brief description of these well-developed
concepts of promoting research use. Further reading on the
subject could include Lomas [38] and Lavis et al. [39].
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Box 2 below provides further explanation of the frame-
work that was developed and used for data analysis1. In
short, it outlined three areas of strategy, namely (1) the
‘the intended strategy’ (what was planned), (2) ‘the rea-
lised strategy’ (what actually occurred), and (3) ‘the
emergent strategy’ (the lessons learned and adopted into
practice) of the funding organisation.
Longitudinal design and sampling frame
Our research was designed to provide a follow-up on
the work of Tetroe et al. [6]. We drew our sample of
funding agencies from the sample contacted in this 2008
study. With this approach we were able to undertake
analysis of the same cohort at two discrete intervals in
time. In the Tetroe et al. [6] study, a judgement sampling
approach was employed to select funding agencies based
on particular criteria of interest to the research team
undertaking that study [23]. These criteria were (1) na-
tionally scoped agencies and other disease-specific vol-
untary health organisations and (2) agencies that
represented a continuum in or contrast in their KT sup-
port activities.
Data collection protocol
Website reviews and agency templates
A data collection template was developed to gather in-
formation from the website and accessible publications
of each funding agency. These templates were based on
the data collected in the Tetroe et al. [6] study (keeping
to our objective of conducting longitudinal analysis) and
the theoretical categorisation of KT activities provided
by Lavis et al. [14]. Templates were populated with in-
formation such as mandate, annual budget, types of KT
support activities and KT evaluation activities. Following
this initial web-based documenting process, the tem-
plates were sent via email to senior representatives of
each agency for validation, updating and addition of data
that were not available on the agency website or in ac-
cessible publications. The agencies were then asked to
return the completed template to our study team, at
which point a telephone interview was scheduled be-
tween the study research team and the agency.
Semi-structured qualitative interviews
We aimed to conduct telephone interviews with at least
two representatives of each agency, including one senior
representative of the KT function and one senior repre-
sentative of the evaluation function. It should be noted
that, in some cases, the two senior officials were the
same individual, in some agencies an evaluation function
did not exist, and in others a larger group of representa-
tives desired to take part in the interview process and
we agreed to this. The interview protocol was based on
the completion of the agency template and a series of
follow-up questions based on the flow of the discussion
and emergent data of interest. This approach allowed us
to complete the deductive learning exercise driven by
the predefined template, but also to complement these
data with new information on why and how any KT ac-
tivities were being implemented in the eyes of the fund-
ing agency, and to allow the interviewer to probe further
on issues of particular interest [24].
All interviews, except the CIHR interview, were con-
ducted by telephone in either French or English. The
CIHR interview was conducted in-person in the CIHR
Box 2 Intended→ Realised→ Emergent (IRE)
framework for strategy classification
Intended strategy (the planned knowledge translation (KT)
strategy) – Includes actions such as defining KT, setting clear KT
objectives or goals, mapping these objectives within internal and
external structures, mechanisms and constraints (in a realist or
classical empiricist way), defining stakeholders (intended and
unintended), drawing identified factors into implementation
theories for KT programmes.
Evaluator’s use ‘intended strategy’ to first understand programme
purpose and to then construct measures for programme or
organisational assessment. Robust evaluations will consider intended
strategy during methodological design. Typically, these intentions are
developed by evaluators in constructs such as ‘theories of change’,
‘logic models’, ‘logframes’, etc. All of these tools hold the same general
purpose of articulating a programme’s intended strategy and results
in more depth and detail than a stated objective.
Realised strategy (the KT strategy that was executed) – Includes
the actual KT programmes, initiatives and activities of the funding
agency.
Evaluators use these elements as the ‘object of assessment’
or ‘evaluand’. Evaluation activities related to this will include actions
such as designing evaluation studies, monitoring and collecting data,
analysis and interpretation of data and communicating findings.
Here, evaluations would identify KT support that was working as
intended and that which was not as well as unpacking the
mechanisms, contexts and systems that govern success.
Emergent strategy (KT strategy evolving from evaluation use) –
Includes the broad range of actions related to using evaluation
findings in KT programme refinement, development, overhaul or
cessation (i.e. evidence-based decision-making). In other words, the
evidence-based direction that an agency embarks upon.
Evaluators produce knowledge related to a realised strategy that,
through the complex process of uptake and implementation, is built
into the re-thinking of strategy (e.g. confirming status quo, course
correction or complete cessation). In the evaluation literature, this is
referred to as ‘evaluation use’ and is manifested in evidence-based action.
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Ottawa, Canada, office. On average, interviews lasted be-
tween 30 and 90 minutes. Notes from any French lan-
guage interview were translated into English by two
bilingual members of the research team independently,
and independent translations were cross-checked for
consistency and accuracy. To minimise the threat of de-
scription or interpretation bias following the interview,
the notes and the completed agency templates were
returned to each agency for validation.
Research ethics
Ethics approval for this project was granted by the Ottawa
Hospital Research Institute, in Ottawa, Ontario, Canada.
Results
The following section of the paper reports on the results
of our research and preliminary interpretation. The sec-
tion is divided into three parts. In the first, we present an
overview of the 26 agencies included in the research. In
the second, we explore the role of KT at the funding
agency, in other words, how funding agencies have posi-
tioned KT for their agency in a qualitative and quantitative
sense. In the third, we outline the KT initiatives being of-
fered and undertaken at the funding agency, taking stock
of and analysing actual KT strategies, programmes, fund-
ing mechanisms and evaluations of these efforts.
Agency overview (region, focus, funding source, budget)
Table 1 provides a brief overview of the regions and agen-
cies included in the study. It also displays those which
were not in the study, but were involved in the t1 period
research (from here forward the Tetroe et al. [6] project
will be referred to as t1 and this project as t2). The seven
agencies not included in this report were removed from
the sample due to an inability to schedule an interview or
an interview request being declined. Although it would
have been possible to proceed with using publically avail-
able data, it was deemed that this would lead to questions
about accuracy. Further, a brief description of the focus of
each agency is included as well as the agencies’ overall an-
nual budget at the time of contact.
The position of KT at the funding agency
KT can be supported by a funding agency in a multitude
of ways; however, the way that KT is positioned within the
funding agency – explicit or implicit – is an important in-
dicator of the level of significance it holds and the impact
it may eventually have. We have used five measures to
allow us to identify and investigate the intended role for
KT at each of our sampled funding agencies. Then, by ag-
gregating data, we can examine regional, global and longi-
tudinal trends. Our five measures are (1) language used to
describe KT, (2) mandating KT, (3) a senior agency mem-
bers’ priority rating of KT, (4) human resources devoted to
KT, and (5) financial resources devoted to KT. Results re-
lated to each of these measures are reported in turn in the
following sections of the manuscript.
KT terminology
As a follow-up to the t1 study, we looked to identify terms
that funding agencies were using to describe the concept
of translating research into action – what we refer to in
this paper as KT. Through agency website scans and
follow-up interviews with agency staff, we identified a total
of 38 terms in use by the 26 agencies studied.
In the t1 study, 29 terms were identified, and there-
fore, over time, there has been an increase in the num-
ber of terms used to describe the KT concept within
funding agencies, even though the number of funders
studied decreased by seven between the two study pe-
riods (Table 2). One might interpret this growth in
terminology over time in a number of ways. On the one
hand, it could be seen as a popularisation of the concept,
as further definitions are being used. On the other, it
could be interpreted as a lack of coordination and
consistency in KT conceptualisation from one agency to
another. We discuss our understanding vis-à-vis other
findings of our research in the Discussion and
Conclusions section of this paper.
Mandating KT
Perhaps the most palpable indicator of KT’s intended
prominence at a funding agency is whether or not the
agency includes the concept in its mandate. A mandate is
the publically stated raison d’etre of an organisation, and
is often legislated by an external body such as a Parliament
or Board of Directors. To assess this, we scanned agency
mandates to look for terms or concepts describing KT –
not specifically the term knowledge translation. We vali-
dated our result for each agency in the follow-up interview
with the funder. Of the 26 funding agencies involved, we
identified that 20 (77%) included the concept of KT dir-
ectly in their agency mandate. This result indicates that
the majority of research funders in our sample publically
declare that KT is a part of their core mission. However,
data also indicates that the inclusion of KT in the mandate
is an emerging trend. As Fig. 1 shows, the number of
agencies including KT in their mandate has increased
from t1 to t2.
Every global region studied demonstrates an increase
in the inclusion of KT in funding agency mandates, save
Australia, where mandate inclusion did not decrease but
remained unchanged. At the individual agency level, we
found that none of the agencies that included KT at t1
had removed the concept at t2.
Stemming from terminology and mandate reviews,
we aimed to collect data on additional indicators of the
intended role of KT at the health research funding
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Table 1 Overview of funding agencies studied
Country Abbreviation Organisation Source of funds;
Regional focus
Annual budget (CAD millions
converted at time of contact)
Total Funding Agency Sample (n = 26)
Australia (n = 3) CCA Cancer Council Australia Charitable; National 16.5 (research specific)
NHFA National Heart Foundation of Australia Charitable; National 71
NHMRC National Health and Medical Research Council Public; National 774.5 (research specific)
Canada (n = 9) AI (formerly
AHFMR)
Alberta Innovates (formerly Alberta Heritage
Foundation for Medical Research)
Public; Provincial 91.9
CHSRF Canadian Health Services Research Foundation Public; National 15.2
CIHR Canadian Institutes of Health Research Public; National 1000
FRSQ Fonds de recherche en santé du Quebec Public; Provincial 100
MSFHR Michael Smith Foundation for Health Research Public; Provincial 33
CCRI (formerly
NCIC)
Canadian Cancer Society Research Institute
(formerly National Cancer Institute of Canada)
Charitable; National 41
NSHRF Nova Scotia Health Research Foundation Public; Provincial 4.9
SHRF Saskatchewan Health Research Foundation Public; Provincial 6
SSHRC Social Sciences and Humanities Research Council Public; National 350.9
Netherlands
(n = 1)
ZonMW Netherlands Organization for Health Research
and Development
Public; National n/a
Denmark (n = 1) FSS Danish Agency for Science, Technology
and Innovation – Danish Council for Independent
Research – Medical Sciences
Public; National 44
Norway (n = 1) RCN Research Council of Norway Public; National 1261
United Kingdom
(n = 7)
AS Alzheimer’s Society Charitable; National 124
CSO Chief Scientist Office Public; National 106
HF Health Foundation Charitable; National 42
NHS HTA National Health Service – Health Technology Assessment Public; National 14
NIHR HS&DR National Institute for Health Research; Health Services
and Delivery Research
Public; National 18
UK MRC UK Medical Research Council Public; National 1215
WT Wellcome Trust Charitable; National 968
United States
(n = 4)
AHRQ Agency for Healthcare Research and Quality Public; National 370 (research specific)
NIH-NCI National Institutes of Health – National Cancer Institute Public; National 5300
RWJF Robert Wood Johnson Foundation Charitable; National 400
VA U.S. Department of Veteran Affairs Public; National 18
Agencies not included from Tetroe et al. [6] (n = 7)
France AFM Association Française Contre les Myopathies Charitable; National n/a
INSERM Institute National de la Santé et de la Recherche
Médicale
Public; National n/a
MOH Ministry of Health: Programme Hospitalier de la
Recherche Clinique
Public; National n/a
Netherlands ZN (Formerly
CVZ)
Zorginstituut Nederland (formerly College voor
Zorgverzekeringen)
Public; National n/a
Sweden SMRC Swedish Medical Research Council Public; National n/a
United Kingdom UK DH United Kingdom Department of Health Policy Research Public; National n/a
United States CDC Centre for Disease Control Public; National n/a
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agency. Table 3 displays the results for the three add-
itional measures of KT positioning at funding agencies,
namely (3) self-prioritisation of KT, (4) human re-
sources devoted to KT, and (5) financial resources de-
voted to KT.
KT prioritisation
KT prioritisation is unique to this period of data collec-
tion. The intent of introducing this data point was to
capture, and subsequently compare, a challenge which
arose quite frequently in the qualitative aspects of the
t1 research. The difficulty we observed was that agency
representatives reported in the interview stage that KT
was of a certain priority at their agency, although they
did not have precise written policy, budgetary or other
‘hard’ documented evidence to support this claim.
Given that our interviews were performed with senior
officials of each agency (in many cases up to the VP
level), and that the vision of a leader may potentially be
used to judge the importance of an idea, we designed a
simple categorical tool for the collection and classifica-
tion of these claims.
In interviews, we discussed why and how they
reached the agency score they did. We found that,
when respondents were given the opportunity to ex-
plain the numeric rating given to their agency, they fre-
quently asserted that KT was becoming an increasingly
important global objective and that the interviewee’s in-
dividual funding agency was well-attuned to this trend
and following suit. This finding is aligned to the data
Fig. 1 Change in knowledge translation inclusion in agency mandate over time
Table 2 Terminology used to describe ‘Knowledge translation’ (KT) over time
Terms used to describe KT by participating
funding agencies (as reported in interviews)
in t1 and not in t2, n = 6
Terms used to describe KT by participating
funding agencies (as reported in interviews)
in t1 and t2, n = 23
New terms used to describe KT by
participating funding agencies
(as reported in interviews) in t2, n = 15
Applied health research
Competing, coordination, co-optation
Knowledge cycle
Science communication
The third mission
Transmission
Capacity-building
Diffusion
Dissemination
Exploitation
Getting knowledge into practice
Impact
Implementation
Knowledge communication
Knowledge exchange
Knowledge management
Knowledge mobilisation
Knowledge transfer
Knowledge translation
Linkage and exchange
Popularisation of research
Research into practice
Research mediation
Research transfer
Research translation
Teaching
Translation
Translational research
Utilisation
Action cycle
Application
Coordination
Dialogue
Implementation science
Knowledge movement
Knowledge promotion
Knowledge sharing
Knowledge use
Manualising interventions
Policy and practice cycle
Spread
Scaling
Translating research into practice
Uptake
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presented earlier demonstrating the growing trend of
embedding the KT concept within the agency’s
mandate. The generally high scores of KT prioritisation
across agencies and regions indicate a trend of increas-
ing KT importance within our cohort. However, when
compared to other proxy measures of the ‘KT role’ at
an agency (staff and budget), we did not see any par-
ticularly compelling patterns emerge.
Human resources devoted to KT
In examining human resources devoted to KT, each
agency was asked to self-interpret and self-classify who
was considered KT staff. Through semi-structured inter-
views, we then aimed to identify underlying reasons for
these classifications. Interestingly, there is a divergence
in who is defined as KT staff across agencies. To give an
example, in the United States agencies, definitions of
staff varied substantially. The Robert Wood Johnson
Foundation held a broad view, including its nine evalu-
ation staff as KT staff, suggesting that a focus on learn-
ing and programme improvement are both an evaluative
duty and a part of the agency’s KT approach. In contrast,
the National Institutes of Health National Cancer Insti-
tute reported its dedicated Implementation Science
Team, a group that works directly on issues of KT con-
ceptualisation and programming with the organisation
and with its research community. Many agencies in-
cluded communications groups in their calculation of
KT staff. Further, the Agency for Healthcare Research
and Quality suggested that the embedded nature of the
Table 3 Agency knowledge translation (KT) prioritisation, human resources and financial resources
Country Agencya KT prioritisationb,c KT staffc,d Annual budget for KT (CAD millions)c,e
Australia CCA n/a 1 2.9
NHFA ‘High’ 0 44
NHMRC 5 80 n/a
Canada AIHS 5 3 0.34 + embedded
CHSRF 5 Embedded Embedded
CIHR 4 15 30 + embedded
FRSQ 3 or 4 0 5
MSFHR 5 2 0.45
CCSRI 5 Embedded Embedded
NSHRF 5 1 n/a
SHRF 4 0 Embedded
SSHRC n/a 2 24.5–31.6
Netherlands ZonMW n/a 20 n/a
Denmark FSS n/a n/a Embedded
Norway RCN n/a n/a Embedded
United Kingdom AS 4 Embedded Embedded
CSO n/a 1 0.62
HF 3 Embedded 0.40
NHS HTA 4 n/a n/a
NIHR HS&DR 3.5 2.5 2.4
UK MRC 5 15–20 Embedded
WT 5 45 Not fixed
United States AHRQ 5 300 31
NIH-NCI 4 7 n/a
RWJF 5 35 340
VA 5 Embedded Embedded
aFor the full agency names, please refer to Table 1.
bFor KT prioritisation scores, a 5-point Likert scale was provided to the respondent. The scale was structured as: 5 – Very Important; 4 – Important; 3 – Neither
important nor unimportant; 2 – Unimportant; 1 – Very unimportant
cNo responses were forced in any part of this research, and so, in several instances ‘n/a’ is recorded as the data point d‘Embedded’ was assigned to the ‘KT Staff’
column when the agency indicated KT is ‘a part’ of the duties of all, or a subset, of employees. Though none are assigned to it in particular
eThe ‘Annual Budget for KT’ column includes funds reported by the agency for KT specifically. This may include funds for agency staff or KT activities such as
grants or awards. Agencies themselves reported these figures, and we interpret that they are best positioned to have decided what counts as KT-specific funds for
them; we caution that this does imply different uses of funds were being reported by different agencies
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KT work at their organisation meant that all employees
should be counted as KT staff. This variation in inter-
pretation of who constitutes KT staff was not restricted
to the United States. We did not discern any trends in
types of staff (e.g. communications, evaluation, consider-
ing all staff as KT) being classified as KT in one region
but not in another.
Although not indicative of any generalisable differ-
ence in resource support (given our purposeful sam-
pling approach and differences in regional sample
characteristics), the data illustrates that the United
States currently devotes the largest human and financial
resource contributions to the KT objective at the fund-
ing agency level.
As human resources devoted to KT was not a variable
collected in the t1 study, we were unable to perform any
comparative analyses across time.
The over-arching finding of this line of analysis is that
there is no generally accepted view of who constitutes
KT staff at a research funding agency.
Financial resources devoted to KT
Given that financial resources devoted to KT were mea-
sured in both the t1 and t2 studies, we performed vari-
ous comparative analyses on KT budget data received
from each agency. However, none of these proved, in
our view, to provide enough insight into KT spending
trends at funding agencies to warrant further demon-
stration and/or data tables in this manuscript. Further-
more, we concluded that there was limited value in
presenting changes in KT spending per region or per
agency given multiple, significant confounding factors
that would limit the ability to interpret such analysis (e.
g. changes in total agency budgets versus KT budgets,
currency inflation, regional variation in inflation, cur-
rency conversation and exchange rate fluctuations over
time). That being said, one trend did emerge, namely
that, across all regions, the number of agencies that
could provide a precise budget figure for KT did not
change significantly. In other words, the number of
agencies earmarking KT funds remained generally the
same across time.
For a closer look at this issue, we unpacked the more
recent t2 data further. In summary, less than half of all
agencies interviewed (11 of 26) were able to identify a
specific amount devoted to KT. Ten of 26 reported that
the KT spending of the organisation could not or should
not be seen as an independent budget line, but instead
that KT was embedded-in across the organisation’s ex-
penditures. Seven of 26 agencies were unable to provide
any funding details related to KT, which was in contrast
with the fact that only one of 26 was unable to publically
disclose any budget information. In sum, these data indi-
cate that earmarking KT financial resources is not the
norm across any region or the sample at large. To better
understand the return on KT activities, this may be a
useful area of data for agencies to track more closely in
the future.
KT initiatives
In this section, we turn to the specific programmes,
mechanisms, modalities, activities, etc., that funding
agencies were using to support KT.
Figure 2 presents the classification of agency initiatives
across the three parts of our analytic framework, namely
push, pull, and linkage and exchange (see Box 1 in the
Methods section of this paper for a full description).
Given the sampling approach employed, we caution
against advanced quantitative comparative interpret-
ation. We consider these data as categorical.
Most agencies favour linkage and exchange (or inte-
grated KT (IKT)) and push efforts over pull efforts.
There were a substantial number of IKT programmes
supplementing the funders’ support for traditional pro-
grammes of curiosity-driven research. Qualitative inter-
view data did not provide any clear conclusion on why
Fig. 2 Number of push, pull, linkage and exchange programmes by country
McLean et al. Health Research Policy and Systems  (2018) 16:44 Page 9 of 15
these trends toward push and linkage and exchange ef-
forts existed.
Although any regional analysis should be made with
caution, a pattern does emerge with regards to
programme distribution across category, namely that
agencies and regions offer a general mix of program-
ming, which is consistent with what is considered by
Lavis et al. [14] to be a favourable approach.
At t1, more attention was paid to the activities the fund-
ing agency required of researchers vis-a-vis the activities,
either planned or unplanned, of the funding agency in
support of KT. To address this, we restructured our classi-
fication of programmes in Fig. 3 by grants, awards and fel-
lowships. Note that a single programme – the base unit in
our above analysis (Fig. 2) – could include a series of
grants or awards or fellowships. It should also be noted
that Fig. 3 showcases programmes that were strategically
designed for KT and does not include grants, awards or
fellowships that were not designed specifically for KT, but
may support KT due to the independent decision of a
grantee to undertake KT.
The primary finding of this analysis is that the funding
agencies are more involved in KT grant dispersion than
other forms of KT support activity like awards or fellow-
ships. To facilitate more precise interpretation, a com-
parison of how this trend in KT support varies from
other areas within the health sciences would be a valu-
able area of additional study, e.g. investigating how the
balance of grant, award and fellowship opportunities for
KT compare to the balance of opportunities available for
clinical trials, laboratory science, vaccinology and health
systems research.
Evaluation
The final area of findings reported in this manuscript
describes an investigation of the evaluation of KT being
conducted at funding agencies. Evaluation is selected as
a focus area for two distinct reasons. First, KT evaluation
has been identified as a significant gap in published ex-
pert opinion, theoretical research and empirical research
[6, 14, 25–29]. Second, in the t1 research, there were no
evaluations identified in any of the 33 agencies studied;
however, nearly all 33 agencies articulated that plans and
designs for evaluations were underway. As a result, a
specific follow-up on progress with evaluation was
prioritised for t2. In other words, an objective for t2 was
to provide more than a stock-taking of programmes and
practice at funding agencies, it was also to dig into the
evidence guiding these efforts.
Given our specific focus for this study – KT activities/
support at the funding agency – we purposefully
reviewed evaluation undertaken at the funding agency
level only, that is to say, an evaluation that focused on
the KT programmes and activities of the funding agency.
We did not include any evaluation being done by funded
researchers in their own projects or the health interven-
tions of others, even if this evaluation was funded by an
agency in our sample (e.g. a large body of work being
performed through the National Health Services – Ser-
vice Delivery and Organization, e.g. [30, 31])1. Our aim
was to learn about funding agency programmes and
practice specifically. Table 4 illustrates evaluation
activities being conducted of funding agencies’ KT
programmes and practice; it utilises the Intended,
Realised, Emergent (IRE) framework articulated in Box 1
of this manuscript.
Data indicates that funding agencies are putting con-
siderable effort and resources into thinking through KT
theories and objectives but much less into carrying out
critical evaluations of these efforts/resources. Indeed,
23/26 funding agencies had a defined and planned KT
strategy to some extent (recall 20/26 are currently in-
cluding the concept in their agency mandate), yet only
7/26 had evaluated KT efforts and only 1/26 could
demonstrate that evaluation results had been used to
guide KT programmes or practice (i.e. to support
Fig. 3 Number of knowledge translation (KT) grants, awards and fellowships by country
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evidence-based decision-making). In other words, a
commitment to KT is evident, but learning-focused
programming of KT was rare.
A deeper dive into the three components of the IRE
framework helps to further understand the agencies’
KT strategy. See Box 2 in the Methods section of the
manuscript for a full description of the IRE conceptual
framework.
Intended strategy
In terms of ‘intended strategy’ there is a strong base of
activity and effort in our sample of funding agencies.
The majority of this effort was in setting a KT definition
and outlining a series of KT goals. A minority of agen-
cies had derived implementation theories (e.g. a theory
of change) to describe the intended process and results
of their KT efforts. One of these was the National Insti-
tutes of Health National Cancer Institute’s Implementa-
tion Science team. This agency has worked to articulate
a theory of KT implementation, integrated a research
translation continuum, and developed a set of contin-
gencies and considerations into their KT support pro-
cesses. Another example was CIHR, who had articulated
a KT Funding Program logic model, and initiated an
evaluation of the organisations strategic intentions for
KT, by using this model in the evaluation design to out-
line expected KT results and critical assumptions.
Realised strategy
In terms of ‘realised strategy’, we have included all evalu-
ation activities related to the assessment of realised or-
ganisational KT strategy. Table 4 indicates a decline in
activities as we move from ‘intended’ to ‘realised’ strat-
egy. Some insight into why this was the case was uncov-
ered in the qualitative interviews. While the vast
majority of agencies asserted that they deemed the
evaluation of their KT funding to be a paramount en-
deavour, they also informed the research team that they
did not have a firm grounding in how to undertake this
task. Generally, it was suggested by agency representa-
tives that research evaluation was a difficult undertaking;
however, evaluating the translation of research into ac-
tion was the most difficult component of this problem.
Emergent strategy
‘Emergent strategy’ is not surprisingly deficient when
considered in relation to the trend of decreasing activity
moving from ‘intended’ to ‘realised’ strategy documenta-
tion. At the time of data collection, only one agency
(Alberta Innovates, a Canadian public Provincial funder)
was using KT-specific evaluation results to inform
decision-making and action.
Discussion
As health policy, practice and programming continues
to lag behind research-generated knowledge, KT remains
a crucial objective within the health system. As has been
argued in the past [32], the funding agency role in sup-
porting KT has merit for a number of reasons. In this
manuscript, we premise this argument on the position
that incentive-setting power funders occupy, given the
control they hold over financial resources. Playing the
role of financier to the research enterprise places funders
in an influential position to stimulate action around a
particular topic such as KT. As Nobel Prize winning
economist Joseph Stiglitz has recognised:
“…the scientists whose research and ideas have
transformed our lives in the past two hundred years
have, for the most part, not been motivated by the
pursuit of wealth. This is fortunate, for if they had,
Table 4 Intended→ Realised → Emergent (IRE) Framework classification of agency knowledge translation (KT) evaluation activitiesa
Intended strategy Realised strategy Emergent strategy
Definition; KT objectives;
KT implementation
theory, etc.
KT evaluation/
learning objectives
Evaluation methods
for KT developed
Analysis and
communication
of findings
Uptake of evaluation
evidence by funding
agencyb,c
Australia (3) 2/3 1/3 1/3 1/3 0/3
Canada (9) 8/9 5/9 3/9 3/9 1/9
Europe (3) 3/3 0/3 0/3 0/3 0/3
United Kingdom (7) 6/7 5/7 2/7 2/7 0/7
United States of America (4) 4/4 1/4 1/ 4 0/4 0/4
Total (26) 23 12 7 6 1
aThis table includes only those activities focused specifically on KT and omits any which were considered ‘embedded’ in broader research quality assessments or
operational reviews. This decision was based on agency representatives being categorically unable to elaborate what and how KT aspects and activities were
‘embedded’ in any broader evaluation when probed during interviews. This was corroborated in our review of the evaluation report or other related documentation.
bAIHS is the only agency to have completed a health research funding evaluation which they could demonstrate evidence to show it has been used to inform agency
practice. cAfter the completion of data collection, but before publication of this manuscript, CIHR completed and delivered its KT evaluation to its senior management
committee; it is not included in the classification to uphold data consistency
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they would have become bankers and not scientists.
It is the pursuit of truth, the pleasure of using their
minds, the sense of achievement from discovery – and
the recognition of their peers – that matters most.
Of course, that doesn’t mean they will turn down
money if it is given to them.” [33]
Positioning KT with funders
The purpose of this research was to take stock of how
various funders are supporting KT and how well they are
doing. In general, the 26 funding agencies whom we en-
gaged demonstrated that KT is a high and a still growing
priority. As mandates are changed (and maintained) to
include the concept of KT, we interpret this to mean
that governments and other health research funders are
concerned with making research useful and actionable.
Previous studies on the role of the funding agency in
KT (e.g. [6, 25, 34]) have argued that a common defin-
ition and/or classification of KT would be beneficial, and
some suggest that a systematic framework to knowledge
translation would contribute to conceptual clarity in the
field [25]. We do not find evidence to disprove this hy-
pothesis, but the findings of our research give us limited
reason for concern. We suggest the diversity of experi-
ence across funders, by country, region, agency size and
by agency type, is a representation of the diversity of
context in which these organisations operate. We see no
reason to conclude this is problematic. In our opinion, it
is more than likely beneficial that programmes and strat-
egies are contextually grounded.
At the same time, some trending in funder practice is
evident. This study has identified further divergence in
terminology over time (since 2008). It also uncovers a
convergence of KT initiatives which funders are using to
further their KT agendas. The prevalence of push efforts
and linkage and exchange (or IKT) efforts, and the pref-
erence towards grants to support these, appears as a
trend across our global sample. The emergence of IKT
programming in particular represents a notable shift
from traditional research funding approaches that have
tended to favour the researcher over research users.
Without robust evaluation data we cannot examine the
evidence base for why these programmes and mecha-
nisms are favoured, or appraise their effectiveness.
However, we can offer some interpretation. First, and
perhaps most likely, the similarity in programming and
grant making activities might represent the emergence
of an accepted framework for KT support based on in-
formal exchanges between agencies. If this is the case,
we note some concern that, in the absence of evalua-
tions, the convergence of KT support activities may rep-
resent an emerging groupthink process rather than the
co-development of a set of proven good practices.
Secondly, although we would argue unlikely, these inter-
national patterns could be coincidental. Again, further
evaluation would help to shed better light on the issue.
KT evaluation – still, an area for action
In the 2008 t1 study, we identified a significant gap in
funders’ execution and ability to execute evaluations of
KT efforts. As a result, in this t2 research, we set an
intentional focus on the issue of KT evaluation in order
to learn how evaluation practice had evolved over time
and to collect complete evaluations in order to investi-
gate the possibility of synthesis and meta-evaluation.
We aimed to better understand and analyse evaluation
activities by developing and applying the IRE framework
(Box 2). This tool allowed us to identify, and subse-
quently investigate, evaluative and strategic strengths
and weaknesses across agencies. In essence, the IRE
framework enabled us to look beyond a simple count of
evaluation reports or the potential undertaking of a syn-
thesis of evaluation findings. Using the framework facili-
tated meaningful conclusions about the evaluation and
strategy process. We would encourage those agencies
who wish to improve their evaluation and strategy func-
tions to consider a conceptual framework such as this,
in particular for identifying areas for organisational im-
provement and/or cross-agency exchange, and we sug-
gest the results of this research may provide some
starting points. For example, applying the IRE frame-
work highlighted how ‘intended KT strategy’ is relatively
well developed across our sample of funders. Therefore,
‘intended strategy’ activities such as designing KT fund-
ing programmes, setting an organisational KT strategy,
or developing KT theories of change, would be an im-
mediately actionable and data-rich area of cross-agency
learning and exchange.
Our data shows a substantial base of intended KT evalu-
ation activities across the agencies and global regions in
the sample. However, findings also highlight a significant
lack of progress in undertaking targeted evaluations of KT,
communicating results of these evaluations, and using
findings of these evaluations to inform funder practice
and policy. At the time of data collection, only one of the
agencies in our sample had completed a targeted evalu-
ation of KT. Though several agencies had evaluations that
were underway or planned, it is important to recall the
same was found in the t1 study (when nearly all agencies
reported plans for KT evaluation). A clear conclusion is
that evaluative data is not being used to measure progress
against the objectives set out in earlier stages of KT
programme design and planning. Given that the under-
lying objective of KT lies in moving evidence into action,
it is paradoxical that the funders of KT do not employ this
philosophy in their own work.
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At the same time, this research has uncovered a lack
of methodological know-how for evaluating KT as a
major stumbling block for agencies who generally indi-
cate a genuine interest in improving KT practice. As
such, we suggest this is an area ripe for researcher (not
just funder) focus. We also learned that funding agen-
cies, themselves faced with budget austerity, do not al-
ways have the ability to make evaluations a priority, and
especially the more challenging evaluations such as one
focused on KT. Although we can understand this pre-
dicament, we do not agree that underfunding critical re-
flection is a sustainable cost-savings approach. We hope
that identifying the persistent lack of KT-focused evalu-
ation at funding agencies, both globally and across type
of agency, will assist in kick-starting evaluative work. In
our interviews with funding agencies, we heard great
interest and genuine intention to undertake evaluations
should the technical know-how be advanced and finan-
cial resources be available. We hope this research is used
to support the cause.
Study limitations
Although we are confident that our methodological ap-
proach allowed us to capture an accurate snapshot of
KT activities at each agency, we caution that, because we
did not interview all departments or branches of each
agency, we cannot claim with absolute certainty that all
KT activities have been identified.
The research reported in this manuscript has focused
on the intentional efforts of funders to support KT.
Focusing on the intentional may not have captured all
KT activities supported. KT activities may go unreported
when they have occurred as a part of a funding agency
programme that is not intentionally supporting KT, par-
ticularly when they occur by decision of a grantee or
awardee. For example, a researcher may decide to use a
portion of a research grant to organise a meeting with
hospital managers to discuss their findings; this activity
has been technically supported by the funding agency
with the grant, but it may not have been directed or re-
corded by the funding agency as KT support.
The longitudinal nature of the study design is weak-
ened by the project team’s inability to include seven of
the agencies included in the t1 study [6]. An inability
for the research team to establish a contact at a particu-
lar funding agency meant we removed the agency from
the sample. We did not want to rely on data collected
from the web and document reviews alone. We have no
reason to believe this has introduced any bias into the
study, neither could we identify any characteristic or
quality that removed agencies have eliminated or re-
weighted in this sample vis-à-vis the 2008 sample.
A significant limitation stems from our sample of
funding agencies being from high-income countries and
focused on funding research that addresses high-income
country needs. A review which includes low- and
middle-income country funders was undertaken by
Cordero et al. [25] as a companion to Tetroe et al. [6].
The follow-up to Cordero et al. [25] will be critical to
understand the global story of funding agency support
for KT2.
A limitation in our study design relates to where
we have focused attention in data collection and ana-
lysis. We have purposefully taken a broad view with
this research, engaging 26 funding agencies from
around the world in the study, allowing the identifica-
tion of broad trends and themes for KT practice at
research funding agencies. However, it does not facili-
tate the deep investigation of a particular funding
agency’s experience with KT.
We note, for reader interpretation, the timing between
data collection and publication – data were collected
from funding agencies for this project in 2012/13 (9 to
10 years after the data collection in t1). Readers’ should
interpret the findings accordingly.
Conclusions
In summary, our research confirms that KT is an object-
ive of growing significance for the health research fun-
ders across the high-income regions of Europe, Australia
and North America. The findings demonstrate that there
is no clear-cut standard or practice for implementing
KT at a funding agency. We suggest that KT is an idio-
syncratic matter that relies on the many contextual
factors presented to a particular research funder. There
is very likely no viable one-size-fits-all solution. We sug-
gest that the diversity of experience this research has un-
covered indicates that any sweeping conclusions or
directives for KT at funding agencies should be handled
with caution, and also calls for evaluation of KT in these
different funder contexts to learn what works, for what
type of funder and why.
We suggest that the critical evaluation of KT should
be prioritised and actioned so that evidence-based
decision-making becomes not only the objective of KT
programmes, but also a part of how these programmes
operate and evolve. These evaluations should take into
consideration the particular context of the agency that
undertakes the evaluation, and should make this context
clear in order to facilitate other agencies’ interpretation
of the results. To kickstart and advance high-quality
evaluation, we suggest funders support KT evaluation
experimentation, innovation and collaboration among
each other on the topic. Funders should not feel alone,
this effort may well embrace the researcher community
interested in doing and improving KT. As the signifi-
cance of KT grows for funders, so must the evidence
base to guide it.
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Endnotes
1There were many evaluations conducted by the re-
search community through the CLARHC programme of
the National Health Services – Service Delivery and
Organization, we reference two examples. None of these
evaluations focused on the activity of the funding agency
in support of KT.
2This study is currently in design by authors: RKDM,
JAV, IDG.
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